Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor

Blood

Volumn 92, Issue 12, 1998, Pages 4491-4508

  Armitage, James O ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD11B ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DEXAMETHASONE; FIBRINOGEN RECEPTOR; FLUCONAZOLE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HLA DR ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 3; INTERLEUKIN 5; LEUKOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; PROTEIN KINASE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; ZIDOVUDINE;

ANTINEOPLASTIC ACTIVITY; CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG CLEARANCE; DRUG HALF LIFE; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; LEG ULCER; LEUKAPHERESIS; LEUKOPOIESIS; MUCOSA INFLAMMATION; NEUTROPENIA; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

EID: 0032535052     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.12.4491     Document Type: Review

References (14)

1. Burgess AW, Begley CG, Johnson GR, Lopez AF, Williamson DJ, Mermod JJ, Simpson RJ, Schmitz A, DeLamarter JF: Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor. Blood 69:43, 1987
2. Wong GG, Witek JS, Temple PA, Wilkens KM, Leary AC, Luxenberg DP, Jones SS, Brown EL, Kay RM, Orr EC, Shoemaker C, Golde DW, Kaufman RJ, Hewick RM, Wang EA, Clark SC: Human GM-CSF: Molecular coloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228:819, 1985
3. Cantrell MA, Anderson D, Cerretti DP, Price V, McKereghan K, Tushinski RJ, Mochizuki DY, Larsen A, Grabstein K, Gillis S, Cosman D: Cloning, sequence, and expression of a human granulocyte/ macrophage colony-stimulating factor. Proc Natl Acad Sci USA 82: 6250, 1985
4. Donahue RE, Wang EA, Kaufman RJ, Foutch L, Leary AC, Witek-Giannette JS, Metzger M, Hewick RM, Steinbrink DR, Shaw G, Kamen R, Clark SC: Effects of N-linked carbohydrate on the in vivo properties of human GM-CSF. Cold Spring Harb Symp Quant Biol 51:685, 1986
5. Dorr RT: Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor. Clin Ther 15:19, 1993
6. Hovgaard D, Mortensen BT, Schifter S, Nissen NI: Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor. Eur J Haematol 50:32, 1993
7. Hussein AM, Ross M, Vredenburgh J, Meisenberg B, Hars V, Gilbert C, Petros WP, Coniglio D, Kurtzberg J, Rubin P, Peters WP: Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim) Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemo- therapy. Eur J Haematol 54:281, 1995
8. Nemunaitis J: Granulocyte-macrophage-colony-stimulating factor: A review from preclinical development to clinical application. Transfusion 33:70, 1993
9. Fabian I, Shapira E, Gadish M, Kletter Y, Nagler A, Flidel O, Slavin S: Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation. Leuk Res 16:703, 1992
10. Fleischmann J, Golde DW, Weisbart RH, Gasson JC: Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 68:708, 1986
11. Ho AD, Haas R, Wulf G, Knauf W, Ehrhardt R, Heilig B, Körbling M, Schulz G, Hunstein W: Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma. Blood 75:203, 1990
12. Jones T, Stern A, Lin R: Potential roles of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant. Eur J Clin Microbiol Infect Dis 13:S47, 1994 (suppl 2)
13. Perkins RC, Vadhan-Raj S, Scheule RK, Hamilton R, Holian A: Effects of continuous high dose rhGM-CSF on human monocyte activity. Am J Hematol 43:279, 1993
14. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109, 1994